Clinical Trial Update: Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update for SG001 Injection in relapsed or metastatic uterine cervical cancer is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Cervical Cancer

Drugs mentioned

• SG001 Injection

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Uterine Cervical Cancer | Phase 2 | Status: UNKNOWN